$FEMY
FEMASYS INC Stock $femy

$femy Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000114036122011032 Filed on March 24, 2022

Income Statement

Concept	2021 Q4	2021	2020 Q4
Revenue	$254.3K	$1.180M	$1.040M
YoY Change	-75.55%	13.66%
Cost Of Revenue	$64.31K	$370.4K	$310.0K
YoY Change	-79.25%	20.83%
Gross Profit	$190.0K	$809.3K	$730.0K
YoY Change	-73.97%	10.65%
Gross Profit Margin	74.71%	68.6%	70.19%
Selling, General & Admin	$1.352M	$4.471M	$2.850M
YoY Change	-52.56%	56.63%
% of Gross Profit	711.54%	552.42%	390.41%
Research & Development	$1.054M	$4.084M	$4.130M
YoY Change	-74.48%	-1.12%
% of Gross Profit	554.59%	504.67%	565.75%
Depreciation & Amortization	$141.9K	$551.1K	$510.6K
YoY Change	-72.22%	-1.73%
% of Gross Profit	74.66%	68.09%	69.94%
Operating Expenses	$2.548M	$9.146M	$7.660M
YoY Change	-66.74%	19.33%
Operating Profit	-$2.358M	-$8.337M	-$6.930M
YoY Change	-65.98%	20.25%
Interest Expense	-$2.870K	$19.23K	$10.00K
YoY Change	-128.7%	53.16%
% of Operating Profit
Other Income/Expense, Net	-$250.00	$803.0K	$10.00K
YoY Change	-102.5%	3924.66%
Pretax Income	-$2.361M	-$7.534M	-$6.910M
YoY Change	-65.83%	8.98%
Income Tax	$4.000K	$4.000K
% Of Pretax Income
Net Earnings	-$2.365M	-$7.538M	-$6.910M
YoY Change	-65.78%	9.01%
Net Earnings / Revenue	-929.84%	-638.97%	-664.42%
Basic Earnings Per Share		-$1.12
Diluted Earnings Per Share	-$199.4K	-$1.12	-$587.6K
COMMON SHARES
Basic Shares Outstanding		6.712M
Diluted Shares Outstanding		6.712M

Balance Sheet

Concept	2021 Q4	2021	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$24.78M	$24.78M
YoY Change		645.98%
Cash & Equivalents	$24.78M		$3.322M
Short-Term Investments
Other Short-Term Assets	$555.9K	$555.9K	$284.1K
YoY Change	95.64%	95.64%
Inventory	$208.3K	$208.3K	$131.4K
Prepaid Expenses
Receivables	$84.26K	$84.26K	$125.8K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$25.63M	$25.63M	$3.864M
YoY Change	563.42%	563.42%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.599M	$2.265M	$1.828M
YoY Change	-12.52%	-21.51%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$655.4K	$655.4K	$792.4K
YoY Change	-17.29%	-17.29%
Total Long-Term Assets	$2.945M	$2.945M	$3.743M
YoY Change	-21.31%	-21.31%
TOTAL ASSETS
Total Short-Term Assets	$25.63M	$25.63M	$3.864M
Total Long-Term Assets	$2.945M	$2.945M	$3.743M
Total Assets	$28.58M	$28.58M	$7.606M
YoY Change	275.7%	275.7%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$445.5K	$445.5K	$674.3K
YoY Change	-33.93%	-33.93%
Accrued Expenses	$603.8K	$603.8K	$1.118M
YoY Change	-45.97%	-45.97%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$587.8K	$587.8K
YoY Change		-44.76%
Total Short-Term Liabilities	$1.692M	$1.692M	$2.889M
YoY Change	-41.43%	-41.43%
LONG-TERM LIABILITIES
Long-Term Debt	$402.4K	$402.4K
YoY Change		-59.42%
Other Long-Term Liabilities	$0.00	$149.8K	$32.90K
YoY Change	-100.0%	-24.3%
Total Long-Term Liabilities	$552.2K	$552.2K	$1.189M
YoY Change	-53.57%	-53.57%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.692M	$1.692M	$2.889M
Total Long-Term Liabilities	$552.2K	$552.2K	$1.189M
Total Liabilities	$2.244M	$2.244M	$4.078M
YoY Change	-44.97%	-44.97%
SHAREHOLDERS EQUITY
Retained Earnings	-$82.74M		-$75.20M
YoY Change	10.02%
Common Stock	$11.92K		$1.110K
YoY Change	973.96%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$60.00K		$60.00K
YoY Change	0.0%
Treasury Stock Shares	$117.2K		$117.2K
Shareholders Equity	$26.33M	$26.33M	-$51.82M
YoY Change
Total Liabilities & Shareholders Equity	$28.58M	$28.58M	$7.606M
YoY Change	275.7%	275.7%

Cashflow Statement

Concept	2021 Q4	2021	2020 Q4
OPERATING ACTIVITIES
Net Income	-$2.365M	-$7.538M	-$6.910M
YoY Change	-65.78%	9.01%
Depreciation, Depletion And Amortization	$141.9K	$551.1K	$510.6K
YoY Change	-72.22%	-1.73%
Cash From Operating Activities	-$2.248M	-$7.931M	-$3.127M
YoY Change	-28.11%	60.77%
INVESTING ACTIVITIES
Capital Expenditures	-$118.6K	$306.9K	-$14.04K
YoY Change	744.87%	3574.19%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$0.00
YoY Change		-100.0%
Cash From Investing Activities	-$118.6K	-$306.9K	-$14.04K
YoY Change	744.87%	-131.69%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$31.74M
YoY Change		20618.05%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-130.7K	29.70M	821.6K
YoY Change	-115.91%	3307.16%
NET CHANGE
Cash From Operating Activities	-2.248M	-7.931M	-3.127M
Cash From Investing Activities	-118.6K	-306.9K	-14.04K
Cash From Financing Activities	-130.7K	29.70M	821.6K
Net Change In Cash	-2.497M	21.46M	-2.319M
YoY Change	7.67%	-793.84%
FREE CASH FLOW
Cash From Operating Activities	-$2.248M	-$7.931M	-$3.127M
Capital Expenditures	-$118.6K	$306.9K	-$14.04K
Free Cash Flow	-$2.129M	-$8.238M	-$3.113M
YoY Change	-31.6%	66.71%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0001339005
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://femasys.com/20211231#OperatingLeaseAndFinanceLeaseRightOfUseAsset
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://femasys.com/20211231#OperatingLeaseAndFinanceLeaseRightOfUseAsset
CY2020Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://femasys.com/20211231#OperatingAndFinanceLeaseLiabilityCurrent
CY2021Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://femasys.com/20211231#OperatingAndFinanceLeaseLiabilityCurrent
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://femasys.com/20211231#OperatingAndFinanceLeaseLiabilityNoncurrent
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://femasys.com/20211231#OperatingAndFinanceLeaseLiabilityNoncurrent
CY2020Q4	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://femasys.com/20211231#OperatingAndFinanceLeaseLiabilityCurrent
CY2021Q4	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://femasys.com/20211231#OperatingAndFinanceLeaseLiabilityCurrent
CY2020Q4	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://femasys.com/20211231#OperatingAndFinanceLeaseLiabilityNoncurrent
CY2020Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://femasys.com/20211231#OperatingLeaseAndFinanceLeaseRightOfUseAsset
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://femasys.com/20211231#OperatingLeaseAndFinanceLeaseRightOfUseAsset
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	true
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2021	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Public Float EntityPublicFloat	53399719
CY2022Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	11804165
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://femasys.com/20211231#OperatingAndFinanceLeaseLiabilityNoncurrent
CY2021Q2	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.11
CY2021	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2021	dei	Auditor Firm AuditorFirmId	185
CY2021	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2024-01-31
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-12-31
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity File Number EntityFileNumber	001-40492
CY2021	dei	Entity Registrant Name EntityRegistrantName	Femasys Inc.
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	11-3713499
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	3950 Johns Creek Court
CY2021	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 100
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	Suwanee
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	GA
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	30024
CY2021	dei	City Area Code CityAreaCode	770
CY2021	dei	Local Phone Number LocalPhoneNumber	500-3910
CY2021	dei	Security12b Title Security12bTitle	Common stock, par value $0.001
CY2021	dei	Trading Symbol TradingSymbol	FEMY
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Auditor Name AuditorName	KPMG LLP
CY2021	dei	Auditor Location AuditorLocation	Atlanta, Georgia
CY2021Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	0
CY2020Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	182490
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	0
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	32895
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	95583558
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-7537845
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-6914992
CY2021	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0
CY2020	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-20
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-7537845
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-6915012
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	153200
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	318640
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-6914992
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-20
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	30022357
CY2021	femy	Automatic Conversion Of Preferred Stock In Connection With Ipo AutomaticConversionOfPreferredStockInConnectionWithIPO	55343686
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	193366
CY2021	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	0
CY2020	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	1189
CY2021	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-504799
CY2020	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	765421
CY2021	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	0
CY2020	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	1000000
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0
CY2020	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	23329
CY2021	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0
CY2020	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	812500
CY2021	femy	Deferred Offering Costs Included In Accounts Payable And Accrued Expenses DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpenses	0
CY2020	femy	Deferred Offering Costs Included In Accounts Payable And Accrued Expenses DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpenses	127479
CY2020	us-gaap	Allowance For Loan And Lease Losses Write Offs AllowanceForLoanAndLeaseLossesWriteOffs	0
CY2021	us-gaap	Allowance For Loan And Lease Losses Write Offs AllowanceForLoanAndLeaseLossesWriteOffs	0
CY2020Q4	femy	Reserves For Uncollectible Accounts ReservesForUncollectibleAccounts	2026
CY2021Q4	femy	Reserves For Uncollectible Accounts ReservesForUncollectibleAccounts	2026
CY2021	femy	Inventory Disposals InventoryDisposals	586
CY2020	femy	Inventory Disposals InventoryDisposals	7388
CY2021Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	850
CY2020Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	896
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	111531
CY2020Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	61270
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	12795
CY2020Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	49650
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	83944
CY2020Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	20458
CY2021Q4	us-gaap	Inventory Net InventoryNet	208270
CY2020Q4	us-gaap	Inventory Net InventoryNet	131378
CY2021Q4	femy	Research Tax Credits ResearchTaxCredits	766571
CY2020Q4	femy	Research Tax Credits ResearchTaxCredits	707290
CY2021Q4	femy	Research Tax Credits Current ResearchTaxCreditsCurrent	184638
CY2020Q4	femy	Research Tax Credits Current ResearchTaxCreditsCurrent	163829
CY2021Q4	femy	Research Tax Credits Noncurrent ResearchTaxCreditsNoncurrent	581933
CY2020Q4	femy	Research Tax Credits Noncurrent ResearchTaxCreditsNoncurrent	543461
CY2021Q4	femy	Research Tax Credits ResearchTaxCredits	766571
CY2020Q4	femy	Research Tax Credits ResearchTaxCredits	707290
CY2021	us-gaap	Depreciation Expense On Reclassified Assets DepreciationExpenseOnReclassifiedAssets	532552
CY2020	us-gaap	Depreciation Expense On Reclassified Assets DepreciationExpenseOnReclassifiedAssets	542519
CY2021	us-gaap	Property Plant And Equipment Disposals PropertyPlantAndEquipmentDisposals	11401
CY2021	us-gaap	Property Plant And Equipment Gross Period Increase Decrease PropertyPlantAndEquipmentGrossPeriodIncreaseDecrease	3098
CY2020	us-gaap	Property Plant And Equipment Disposals PropertyPlantAndEquipmentDisposals	21500
CY2020	us-gaap	Property Plant And Equipment Gross Period Increase Decrease PropertyPlantAndEquipmentGrossPeriodIncreaseDecrease	0
CY2021	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2021	femy	Minimum Term To Record Operating Leases As Right To Use Assets And Operating Lease Liabilities MinimumTermToRecordOperatingLeasesAsRightToUseAssetsAndOperatingLeaseLiabilities	P1Y
CY2021	femy	Minimum Term To Record Finance Leases As Right To Use Assets And Finance Lease Liabilities MinimumTermToRecordFinanceLeasesAsRightToUseAssetsAndFinanceLeaseLiabilities	P1Y
CY2021	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P3Y
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1668951
CY2020Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1668951
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1643858
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1603882
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	25093
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	65069
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	39976
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	118852
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	21799
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	3294
CY2021Q2	us-gaap	Deferred Offering Costs DeferredOfferingCosts	188544
CY2021Q2	us-gaap	Deferred Offering Costs DeferredOfferingCosts	1591143
CY2021Q4	femy	Deferred Offering Costs Capitalized DeferredOfferingCostsCapitalized	0
CY2020Q4	femy	Deferred Offering Costs Capitalized DeferredOfferingCostsCapitalized	202479
CY2021Q4	femy	Accrued Clinical Trial Cost AccruedClinicalTrialCost	301730
CY2020Q4	femy	Accrued Clinical Trial Cost AccruedClinicalTrialCost	289180
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	98272
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	796864
CY2021Q4	femy	Franchise Taxes FranchiseTaxes	103020
CY2020Q4	femy	Franchise Taxes FranchiseTaxes	0
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	100765
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	31557
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	603787
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1117601
CY2020Q4	femy	Clinical Holdback Liability ClinicalHoldbackLiability	164972
CY2021	femy	Clinical Holdback Retained ClinicalHoldbackRetained	15503
CY2021	femy	Clinical Holdback Paid ClinicalHoldbackPaid	11737
CY2021Q4	femy	Clinical Holdback Liability ClinicalHoldbackLiability	168738
CY2021Q4	femy	Clinical Holdback Current ClinicalHoldbackCurrent	18947
CY2021Q4	femy	Clinical Holdback Noncurrent ClinicalHoldbackNoncurrent	149791
CY2019Q4	femy	Clinical Holdback Liability ClinicalHoldbackLiability	145768
CY2020	femy	Clinical Holdback Retained ClinicalHoldbackRetained	19630
CY2020	femy	Clinical Holdback Paid ClinicalHoldbackPaid	426
CY2020Q4	femy	Clinical Holdback Liability ClinicalHoldbackLiability	164972
CY2020Q4	femy	Clinical Holdback Current ClinicalHoldbackCurrent	0
CY2020Q4	femy	Clinical Holdback Noncurrent ClinicalHoldbackNoncurrent	164972
CY2020	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	0
CY2021	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	0
CY2020Q4	femy	Contract With Customer Unsatisfied Performance Obligation ContractWithCustomerUnsatisfiedPerformanceObligation	0
CY2021Q4	femy	Contract With Customer Unsatisfied Performance Obligation ContractWithCustomerUnsatisfiedPerformanceObligation	0
CY2021	femy	Percentage Of Restocking Fee PercentageOfRestockingFee	0.30
CY2021	us-gaap	Advertising Expense AdvertisingExpense	27000
CY2020	us-gaap	Advertising Expense AdvertisingExpense	4125
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2021Q2	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount	812500
CY2021Q2	femy	Extinguishment Of Accrued Interest ExtinguishmentOfAccruedInterest	9015
CY2021	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	821515
CY2021	femy	Number Of Extension Option For Operating Lease Term NumberOfExtensionOptionForOperatingLeaseTerm	2
CY2021	femy	Lessee Operating Lease Option To Extend Term LesseeOperatingLeaseOptionToExtendTerm	P5Y
CY2021Q4	femy	Current Market Rate CurrentMarketRate	1
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	44339
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	635668
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1008887
CY2021Q4	femy	Operating Lease Asset OperatingLeaseAsset	635668
CY2020Q4	femy	Operating Lease Asset OperatingLeaseAsset	1008887
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	383616
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	413211
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	386224
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	769840
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	769840
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1183051
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.10
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.10
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y1M6D
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y1M6D
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	487746
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	490754
CY2021	us-gaap	Short Term Lease Cost ShortTermLeaseCost	3343
CY2020	us-gaap	Short Term Lease Cost ShortTermLeaseCost	0
CY2021	us-gaap	Variable Lease Cost VariableLeaseCost	17497
CY2020	us-gaap	Variable Lease Cost VariableLeaseCost	14326
CY2021	us-gaap	Lease Cost LeaseCost	508586
CY2020	us-gaap	Lease Cost LeaseCost	505080
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	150122
CY2020Q4	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	150122
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset Accumulated Amortization FinanceLeaseRightOfUseAssetAccumulatedAmortization	120043
CY2020Q4	us-gaap	Finance Lease Right Of Use Asset Accumulated Amortization FinanceLeaseRightOfUseAssetAccumulatedAmortization	101503
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	30079
CY2020Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	48619
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	23058
CY2020Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	20861
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	16193
CY2020Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	39252
CY2021Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	39251
CY2020Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	60113
CY2020Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.10
CY2021Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.10
CY2021Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P1Y7M6D
CY2020Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y7M6D
CY2021	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	18540
CY2020	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	18282
CY2021	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	5090
CY2020	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	7078
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	541307
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	557500
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	47029
CY2021Q4	femy	Operating Lease Liability To Be Paid OperatingLeaseLiabilityToBePaid	1145836
CY2021Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	25951
CY2021Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	16792
CY2021Q4	femy	Finance Lease Liability To Be Paid FinanceLeaseLiabilityToBePaid	42743
CY2021Q4	femy	Lessee Operating Lease And Finance Lease Liability Payments Due LesseeOperatingLeaseAndFinanceLeaseLiabilityPaymentsDue	1188579
CY2021Q4	femy	Lessee Operating Lease And Finance Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseAndFinanceLeaseLiabilityUndiscountedExcessAmount	379488
CY2021Q4	femy	Operating And Finance Lease Liability OperatingAndFinanceLeaseLiability	809091
CY2021Q4	femy	Operating And Finance Lease Liability Current OperatingAndFinanceLeaseLiabilityCurrent	406674
CY2021Q4	femy	Operating And Finance Lease Liability Noncurrent OperatingAndFinanceLeaseLiabilityNoncurrent	402417
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	181123
CY2020Q4	us-gaap	Notes Payable Current NotesPayableCurrent	630010
CY2021Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	0
CY2020Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	182490
CY2021Q4	us-gaap	Notes Payable NotesPayable	181123
CY2020Q4	us-gaap	Notes Payable NotesPayable	812500
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.0200
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.0100
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.0300
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.0300
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.0500
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0100
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0100
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.2700
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.1900
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	16873473
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	14975253
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	13920
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	171662
CY2021Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	82451
CY2020Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	67109
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	3190604
CY2020Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	2952047
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	20207
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	20035
CY2021Q4	femy	Deferred Tax Assets Lease Liabilities DeferredTaxAssetsLeaseLiabilities	188789
CY2020Q4	femy	Deferred Tax Assets Lease Liabilities DeferredTaxAssetsLeaseLiabilities	271231
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	8898
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	15281
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	20378342
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	18472618
CY2021Q4	femy	Deferred Tax Liabilities Uniform Capitalization DeferredTaxLiabilitiesUniformCapitalization	10615
CY2020Q4	femy	Deferred Tax Liabilities Uniform Capitalization DeferredTaxLiabilitiesUniformCapitalization	10470
CY2021Q4	femy	Deferred Tax Liabilities Right Of Use Assets DeferredTaxLiabilitiesRightOfUseAssets	138239
CY2020Q4	femy	Deferred Tax Liabilities Right Of Use Assets DeferredTaxLiabilitiesRightOfUseAssets	231283
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	14409
CY2020Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	27898
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	163263
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	269651
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	20215079
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	18202967
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0
CY2020Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	2012112
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1337524
CY2021Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	78264967
CY2017Q1	femy	Number Of Shares Authorized For All Classes Of Stock NumberOfSharesAuthorizedForAllClassesOfStock	169000000
CY2017Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.001
CY2021Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9
CY2021Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9
CY2021	us-gaap	Common Stock Voting Rights CommonStockVotingRights	one
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	17310609
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	17210609
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	17210609
CY2020Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	55835833
CY2020Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	55835833
CY2020Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	55835833
CY2020Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	55343686
CY2020Q4	us-gaap	Temporary Equity Aggregate Amount Of Redemption Requirement TemporaryEquityAggregateAmountOfRedemptionRequirement	55343686
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2021	us-gaap	Dividends Common Stock DividendsCommonStock	0
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	11804165
CY2021Q2	femy	Number Of Equity Incentive Plans NumberOfEquityIncentivePlans	2
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	983889
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.69
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	53056
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.88
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	0
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	187206
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	4.23
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	743627
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.60
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	44698
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.83
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	556
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	27.00
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	8378
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	5.43
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	689995
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.58
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	159062
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	181700
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	689995
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y4M13D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	515834
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	959862
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	959862
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.12
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.12
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-7.20
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-7.20
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P5Y4M17D
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P10Y
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	193366
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	318640
CY2021Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	287748
CY2021	femy	Share Based Compensation Expense To Be Recognized Upon Achieving Certain Performance Condition ShareBasedCompensationExpenseToBeRecognizedUponAchievingCertainPerformanceCondition	155222
CY2021Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	132526
CY2021	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y6M
CY2021	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	0
CY2020	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	14645
CY2020	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	0
CY2021	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	0
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-7537845
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-7537845
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-6914992
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-6914992
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6712028
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6712028
CY2021	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	0
CY2020	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	8116343
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	689995
CY2020	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	743627
CY2021	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	244572
CY2020	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	244572
CY2021	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	934567
CY2020	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	9104542

Files In Submission

Name	View Source	Status
0001140361-22-011032-index-headers.html	Edgar Link	pending
0001140361-22-011032-index.html	Edgar Link	pending
0001140361-22-011032.txt	Edgar Link	pending
0001140361-22-011032-xbrl.zip	Edgar Link	pending
brhc10035438_10k.htm	Edgar Link	pending
brhc10035438_10k_htm.xml	Edgar Link	completed
brhc10035438_ex23-1.htm	Edgar Link	pending
brhc10035438_ex31-1.htm	Edgar Link	pending
brhc10035438_ex31-2.htm	Edgar Link	pending
brhc10035438_ex32-1.htm	Edgar Link	pending
brhc10035438_ex32-2.htm	Edgar Link	pending
brhc10035438_ex4-1.htm	Edgar Link	pending
femy-20211231.xsd	Edgar Link	pending
femy-20211231_cal.xml	Edgar Link	unprocessable
femy-20211231_def.xml	Edgar Link	unprocessable
femy-20211231_lab.xml	Edgar Link	unprocessable
femy-20211231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
image00002.jpg	Edgar Link	pending
image00004.jpg	Edgar Link	pending
image00005.jpg	Edgar Link	pending
image00006.jpg	Edgar Link	pending
image00007.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$FEMY
FEMASYS INC Stock $femy

2021 Q4 Form 10-K Financial Statement

#000114036122011032 Filed on March 24, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FEMY FEMASYS INC Stock $femy

2021 Q4 Form 10-K Financial Statement

#000114036122011032 Filed on March 24, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FEMY
FEMASYS INC Stock $femy